cell adhesion inhibitors (Eli Lilly)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namecell adhesion inhibitors (Eli Lilly)
Drug Alias NameVLA-1 antagonists (ICOS)alpha-D inhibitors (ICOS)MAb 240I (ICOS)integrin program (ICOS)cell adhesion inhibitors (ICOS)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell adhesion molecules modulators
TargetsCell adhesion molecules
Therapy Area/IndicationsInflammationFibrosisCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIcos Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And CompanyIcos Corp
Active IndicationsN/A
Inactive IndicationsInflammationFibrosisCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A